A Multicenter, Randomized, Open-Label, Comparative, Two-Period Crossover Trial of Preference, Efficacy, and Safety Profiles of a Prefilled, Disposable Pen and Conventional Vial/Syringe for Insulin Injection in Patients with Type 1 or 2 Diabetes Mellitus

Clinical Therapeutics

Volumn 25, Issue 11, 2003, Pages 2836-2848

  Korytkowski, Mary ^a   Bell, David ^b   Jacobsen, Carol ^c   Suwannasari, Rudee ^d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c NOVO NORDISK INC   (United States)

^d Clinical Research Center   (United States)

Author keywords

Compliance; Diabetes mellitus; FlexPen ; Insulin aspart; Insulin delivery systems; Insulin pens; Quality of life; Vial and syringe

Indexed keywords

FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INSULIN ASPART; ISOPHANE INSULIN; PROTAMINE INSULIN ASPART; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE ADVERSE EFFECT; DIARRHEA; DISPOSABLE EQUIPMENT; DRUG DELIVERY SYSTEM; DRUG MIXTURE; EQUIPMENT; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PEN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEEDLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTIMAL DRUG DOSE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SAFETY; SYRINGE; UPPER RESPIRATORY TRACT INFECTION;

EID: 0344233275     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(03)80337-5     Document Type: Article

References (15)

1. Hornquist JO, Wikby A, Andersson PO, Dufva AM. Insulin-pen treatment, quality-of life and metabolic control: Retrospective intra-group evaluations. Diabetes Res Clin Pract. 1990;10:221-230.
2. Hanas SR, Ludvigsson J. Experience of pain from insulin injections and needle-phobia in young patients with IDDM. Pract Diabetes Int. 1997;14:95-99.
3. Chantelau E, Schiffers T, Schutze J, Hansen B. Effect of patient-selected intensive insulin therapy on quality of life. Patient Educ Couns. 1997;30:167-173.
4. Kadiri A, Chraibi A, Marouan F, et al. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract. 1998;41:15-23.
5. Da Costa SA. Coordinated approach to insulin transfer in the older type 2 client. J Diabetes Nurs. 1997;1:123-126.
6. Fox C, McKinnon C, Wall A, Lawton A. Ability to handle, and patient preference for, insulin delivery devices in visually impaired patients with type 2 diabetes. Pract Diabetes Int. 2002;19:104-107.
7. Bradley C, Lewis KS. Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabetic Med. 1990;7:445-451.
8. Bashoff EC, Beaser RS. Insulin therapy and the reluctant patient. Overcoming obstacles to success. Postgrad Med. 1995;97:86-90, 93-96.
9. Korytkowski M. When oral agents fail: Practical barriers to starting insulin. Int J Obes Relat Metab Disord. 2002;26(Suppl 3):S18-S24.
10. Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med. 1999;106:57-58, 61-64, 68.
11. Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther. 1998;20:486-496.
12. Reza M, Taylor CD, Towse K, et al. Insulin improves well-being for selected elderly type 2 diabetic subjects. Diabetes Res Clin Pract. 2002;55:201-207.
13. Bradley C, Speight J. Patient perceptions of diabetes and diabetes therapy: Assessing quality of life. Diabetes Metab Res Rev. 2002;18(Suppl 3):S64-S69.
14. Kesson CM, Bailie GR. Do diabetic patients inject accurate doses of insulin? Diabetes Care. 1981;4:333. Letter.
15. Puxty JA, Hunter DH, Burr WA. Accuracy of insulin injection in elderly patients. BMJ (Clin Res Ed). 1983;287:1762.